丹莪合剂治疗子宫内膜异位症的临床及实验研究  被引量:24

Clinical and Experimental Study on the Treatment of Endometriosis with Dan'e Mixture

在线阅读下载全文

作  者:蔡利珊[1,2] 舒晔[1,2] 谢辉英[1,2] 孙琰 王文会[1,2] 毛先珍[1,2] 杜玲 章小琴[1,2] 阎兆珍 傅彩娥[1,2] 

机构地区:[1]昆明医学院第二附属医院 [2]昆明医学院

出  处:《中国中西医结合杂志》1999年第3期159-161,共3页Chinese Journal of Integrated Traditional and Western Medicine

摘  要:目的:寻找治疗子宫内膜异位症(内异症)既有效、副作用又少的药物。方法:应用纯中药制剂———丹莪合剂治疗内异症189例,观察治疗前后一些指标的变化,并且还观察了实验动物模型用丹莪合剂及丹那唑治疗后的情况。结果:内异症患者189例经丹莪合剂治疗9个月,临床痊愈39例占206%;显效67例占354%;有效67例占354%;无效16例占85%,总有效率为915%。与丹那唑同疗程治疗内异症患者160例的总有效率950%比较,无显著性差异。动物实验结果也与临床相似。结论:丹莪合剂是治疗内异症的一种安全、有效的药物,值得进一步研究及开发,特别对该病的早期诊断、早期治疗及预防独具特色。Objective: To find a medicine to treat endometriosis effectively with less side effect. Methods: Dan'e mixture (DEM, consists of Radix Salviae Miltiorrhizae and Rhizoma Zedoariae) was used to treat 189 cases of endometriosis and the change of symptom and sign, the B ultrasonograph, the anti endometrium antibody and endometriosis quantitative diagnostic index were observed, another 160 cases were treated with Danazol as control, also using animal model to treat with DEM and Danazol. Results: One hundred and eighty nine cases were treated for 9 months. According to National Standards, 39 cases (20.6%) were cured, 67 cases (35.4%) were markedly effective, 67 cases (35.4%) were effective, and 16 cases (8.4%) were ineffective. Compared with 160 cases treated with Danazol for 9 months, the total effective rates were 95% and 91.5% respectively, the difference between them was insignificant. Animal experiments showed the similar results to the clinical ones. Conclusion: SZM is a safe and effective medicine to treat endometriosis, which deserves further study and development. It is particularly helpful for diagnosis, treatment and prevention of endometriosis in the early stage.

关 键 词:子宫内膜异位症 丹莪合剂 活血祛瘀 中医药疗法 

分 类 号:R271.917.1[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象